ELAN CORP PLC
DelistedCIK 737572fmd_1JDBGTCHCAZ5YZCC20MHBXH5BJManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2008 to Dec 31, 2012, 5 periods
| Line item | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 |
|---|---|---|---|---|---|
| Total revenues | 1,000 | 1,113 | 44 | 4 | 0 |
| Cost of revenue | 493 | 561 | 12 | 1 | 0 |
| Gross profit | 507 | 552 | 32 | 3 | 0 |
| Realized investment gains (losses) | (22) | (2) | 14 | 2 | (1) |
| Research and development | 323 | 294 | 129 | 107 | 95 |
| Selling, general and administrative | 293 | 268 | 124 | 107 | 114 |
| Total operating expenses | 650 | 520 | 511 | 238 | 378 |
| Operating income | (144) | 32 | (479) | (235) | (378) |
| Interest expense | – | 139 | 119 | 107 | – |
| Interest and investment income | – | (0) | – | (0) | – |
| Other non-operating income (expense) | – | (162) | (135) | (230) | (356) |
| Income before taxes | (297) | (130) | (614) | (466) | (733) |
| Income tax expense | (226) | 46 | (52) | (12) | (361) |
| Net income from continuing operations | (71) | (176) | (561) | (454) | (373) |
| Net income | (71) | (176) | (325) | 561 | (137) |